Kinloch Capital, LLC Merck & Co., Inc. Transaction History

Kinloch Capital, LLC

$203 Million
Q3 2024

A detailed history of Kinloch Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kinloch Capital, LLC holds 4,342 shares of MRK stock, worth $432,115. This represents 0.24% of its overall portfolio holdings.

Number of Shares

4,342

Previous 4,343 0.02%

Holding current value

$432,115

Previous $537,000 8.19%

% of portfolio

0.24%

Previous 0.28%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $111 - $128	-1 Reduced 0.02%	4,342 $493,000
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $32,683 - $35,101	264 Added 6.47%	4,343 $537,000
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $209,041 - $243,579	1,846 Added 82.67%	4,079 $538,000
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $196,252 - $213,570	-1,959 Reduced 46.73%	2,233 $243,000
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $228,343 - $253,583	2,218 Added 112.36%	4,192 $431,000
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $237,747 - $259,133	-2,189 Reduced 52.58%	1,974 $227,000
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $1,441 - $1,608	14 Added 0.34%	4,163 $443,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $1,486 - $1,905	17 Added 0.41%	4,149 $460,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $1,267 - $1,424	15 Added 0.36%	4,132 $356,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $18,284 - $20,726	219 Added 5.62%	4,117 $375,000
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $32,344 - $36,256	440 Added 12.72%	3,898 $320,000
Q4 2021 Jan 20, 2022	BUY	$72.28 - $90.54 $1,228 - $1,539	17 Added 0.49%	3,458 $265,000
Q4 2020 Jan 21, 2021	BUY	$71.77 - $79.65 $246,960 - $274,075	3,441 New	3,441 $281,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kinloch Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kinloch Capital, LLC with notifications on news.

Account

Kinloch Capital, LLC Merck & Co., Inc. Transaction History